PURPOSE: This study describes the design, recruitment, and baseline data of the first smoking-cessation clinical trial for African-American light smokers, Kick It at Swope II (KIS-II). DESIGN: KIS-II was a randomized trial testing the efficacy of nicotine gum (vs. placebo gum) in combination with counseling (motivational interviewing or health education). SETTING: This study was conducted at an urban community-based clinic serving predominantly lower-income African-Americans. SUBJECTS:African-Americans who smoked 1 to 10 cigarettes per day were eligible. Of 1933 individuals screened, 1012 (52%) were eligible and 755 (75%) were enrolled in the study. MEASURES: Baseline assessment included smoking history and psychometric measures. ANALYSIS: The majority of participants were women (67%) with a mean age of 45.1 years (SD = 10.7). Participants smoked on average 7.6 cigarettes (SD = 3.21) per day, had a mean exhaled carbon monoxide level of 13.9 ppm (SD = 8.9) and a mean serum cotinine level of 244.2 ng/mL (SD = 154.4), and reported high levels of motivation and confidence to quit smoking. CONCLUSION:African-American light smokers were motivated to stop smoking and to enroll in a smoking-cessation program. Characteristics of our sample suggest African-American light smokers are an appropriate group for inclusion in smoking-cessation interventions.
RCT Entities:
PURPOSE: This study describes the design, recruitment, and baseline data of the first smoking-cessation clinical trial for African-American light smokers, Kick It at Swope II (KIS-II). DESIGN: KIS-II was a randomized trial testing the efficacy of nicotine gum (vs. placebo gum) in combination with counseling (motivational interviewing or health education). SETTING: This study was conducted at an urban community-based clinic serving predominantly lower-income African-Americans. SUBJECTS: African-Americans who smoked 1 to 10 cigarettes per day were eligible. Of 1933 individuals screened, 1012 (52%) were eligible and 755 (75%) were enrolled in the study. MEASURES: Baseline assessment included smoking history and psychometric measures. ANALYSIS: The majority of participants were women (67%) with a mean age of 45.1 years (SD = 10.7). Participants smoked on average 7.6 cigarettes (SD = 3.21) per day, had a mean exhaled carbon monoxide level of 13.9 ppm (SD = 8.9) and a mean serum cotinine level of 244.2 ng/mL (SD = 154.4), and reported high levels of motivation and confidence to quit smoking. CONCLUSION: African-American light smokers were motivated to stop smoking and to enroll in a smoking-cessation program. Characteristics of our sample suggest African-American light smokers are an appropriate group for inclusion in smoking-cessation interventions.
Authors: Lisa Sanderson Cox; Nicole L Nollen; Matthew S Mayo; Won S Choi; Babalola Faseru; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia Journal: J Natl Cancer Inst Date: 2012-01-25 Impact factor: 13.506
Authors: Billie Bonevski; Christine Paul; Catherine D'Este; Robert Sanson-Fisher; Robert West; Afaf Girgis; Mohammad Siahpush; Robert Carter Journal: BMC Public Health Date: 2011-01-31 Impact factor: 3.295
Authors: Jennifer R Warren; Janet L Thomas; Kolawole S Okuyemi; Bruce Lindgren; Jasjit S Ahluwalia Journal: J Natl Med Assoc Date: 2010-10 Impact factor: 1.798
Authors: Kari Jo Harris; Andrea Bradley-Ewing; Kathy Goggin; Kimber P Richter; Christi Patten; Karen Williams; Hyoung S Lee; Vincent S Staggs; Delwyn Catley Journal: Health Educ Res Date: 2016-04-13
Authors: Babalola Faseru; Lisa S Cox; Carrie A Bronars; Isaac Opole; Gregory A Reed; Matthew S Mayo; Jasjit S Ahluwalia; Kolawole S Okuyemi Journal: BMC Med Res Methodol Date: 2010-01-19 Impact factor: 4.615